Patents Assigned to Teva Pharmaceutical Industries, Limited
  • Patent number: 11472772
    Abstract: The present invention relates to antagonists of the S1P3 receptor formula (A) as herein described and pharmaceutical compositions thereof. The compounds of formula (A) are useful in the preparation of a medicament, in particular for the treatment of Alzheimer's disease.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: October 18, 2022
    Assignee: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Chiara Caramelli, Cesare Federico, Emanuele Gabellieri, Matteo Magnani, Iolanda Micco, Georg C. Terstappen
  • Patent number: 10071206
    Abstract: An injector device includes an injector body that receives a syringe; and an injection assembly being configured to dispense medicament from the syringe in a dispensation step. Certain types of injector devices include a sudden completion indicator that indicates when the injection is completed. Certain types of injector devices are configured to dispense two different medicament formulations having different viscosities from syringes without making any changes to the injector devices other than to switch out the syringes. Certain types of injector devices include safety arrangements that inhibit firing of the injector device until front and rear housing assemblies are disposed in predetermined rotational and axial positions relative to each other.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: September 11, 2018
    Assignee: Teva Pharmaceutical Industries Limited
    Inventor: Toby Cowe
  • Publication number: 20180201582
    Abstract: The present invention relates to antagonists of the S1P3 receptor formula (A) as herein described and pharmaceutical compositions thereof. The compounds of formula (A) are useful in the preparation of a medicament, in particular for the treatment of Alzheimer's disease.
    Type: Application
    Filed: March 16, 2018
    Publication date: July 19, 2018
    Applicant: Teva Pharmaceutical Industries Limited
    Inventors: Chiara Caramelli, Cesare Federico, Emanuele Gabellieri, Matteo Magnani, Iolanda Micco, Georg C. Terstappen
  • Patent number: 9951017
    Abstract: The present invention relates to antagonists of the S1P3 receptor formula (A) as herein described and pharmaceutical compositions thereof. The compounds of formula (A) are useful in the preparation of a medicament, in particular for the treatment of Alzheimer's disease.
    Type: Grant
    Filed: November 28, 2014
    Date of Patent: April 24, 2018
    Assignee: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Chiara Caramelli, Cesare Federico, Emanuele Gabellieri, Matteo Magnani, Iolanda Micco, Georg C Terstappen
  • Patent number: 9827374
    Abstract: An injector device includes an injector body that receives a syringe; and an injection assembly being configured to dispense medicament from the syringe in a dispensation step. Certain types of injector devices include a sudden completion indicator that indicates when the injection is completed. Certain types of injector devices are configured to dispense two different medicament formulations having different viscosities from syringes without making any changes to the injector devices other than to switch out the syringes. Certain types of injector devices include safety arrangements that inhibit firing of the injector device until front and rear housing assemblies are disposed in predetermined rotational and axial positions relative to each other.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: November 28, 2017
    Assignee: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
    Inventor: Toby Cowe
  • Patent number: D783147
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Hugh Fosbury, Nicole McInerney
  • Patent number: D783149
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Hugh Fosbury, Nicole McInerney
  • Patent number: D783150
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventor: David William Cottam
  • Patent number: D783151
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventor: David William Cottam
  • Patent number: D783152
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Hugh Fosbury, Nicole McInerney
  • Patent number: D783153
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventor: David William Cottam
  • Patent number: D783154
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Hugh Fosbury, Nicole McInerney
  • Patent number: D783155
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Hugh Fosbury, Nicole McInerney
  • Patent number: D783156
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Patent number: D783157
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Patent number: D783159
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Hugh Fosbury, Nicole McInerney
  • Patent number: D783804
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 11, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Hugh Fosbury, Nicole McInerney
  • Patent number: D783805
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 11, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Patent number: D783806
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 11, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Patent number: D783807
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 11, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Hugh Fosbury, Nicole McInerney